Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 3 (2006), Issue 8 (August)

1. Emotional experience and facial expression in Alzheimer's disease.
   Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 13(3): 636-51. [Abstract] [Full-text]
2. Short- and long-term implicit memory in aging and Alzheimer's disease.
   Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 13(3): 611-35. [Abstract] [Full-text]
3. Heterogeneity in verbal memory: a marker of preclinical Alzheimer's disease?
   Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 13(3): 503-15. [Abstract] [Full-text]
4. Practice effects on motor control in healthy seniors and patients with mild cognitive impairment and Alzheimer's disease.
   Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 13(3): 385-410. [Abstract] [Full-text]
5. Divergent thinking in Alzheimer's and frontotemporal dementia.
   Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 13(3): 281-90. [Abstract] [Full-text]
6. Treatment monitoring and response prediction with proton MR spectroscopy in AD.
   Neurology, 67(3): 528-30. [Abstract] [Full-text]
7. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
   Neurology, 67(3): 526-7. [Abstract] [Full-text]
8. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI.
   Neurology, 67(3): 467-73. [Abstract] [Full-text]
9. Restriction in complex activities of daily living in MCI: impact on outcome.
   Neurology, 67(3): 461-6. [Abstract] [Full-text]
10. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment.
    Neurology, 67(3): 453-60. [Abstract] [Full-text]
11. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.
    Neurology, 67(3): 446-52. [Abstract] [Full-text]
12. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.
    Neurology, 67(3): 441-5. [Abstract] [Full-text]
13. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Arch Gen Psychiatry, 63(8): 916-24. [Abstract] [Full-text]
14. Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease.
    J Neurochem, 98(3): 939-50. [Abstract] [Full-text]
15. Does the p75 neurotrophin receptor mediate Abeta-induced toxicity in Alzheimer's disease?
    J Neurochem, 98(3): 654-60. [Abstract] [Full-text]
16. Analysis of single Alzheimer solid plaque cores by laser capture microscopy and nanoelectrospray/tandem mass spectrometry.
    Biochemistry, 45(32): 9849-56. [Abstract] [Full-text]
17. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease.
    J Biol Chem, 281(33): 23658-67. [Abstract] [Full-text]
18. Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease.
    Arch Neurol, 63(8): 1165-9. [Abstract] [Full-text]
19. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain.
    Neurochem Int, 49(5): 487-93. [Abstract] [Full-text]
20. Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide.
    Biophys J, 91(5): 1638-47. [Abstract] [Full-text]
21. Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography.
    J Neurol Neurosurg Psychiatry, 77(9): 1060-3. [Abstract] [Full-text]
22. Cardiovascular disease and Alzheimer's disease: common links.
    J Intern Med, 260(3): 211-23. [Abstract] [Full-text]
23. A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid beta in an Alzheimer's disease model.
    J Pharmacol Exp Ther, 318(3): 1248-56. [Abstract] [Full-text]
24. CSF BACE1 activity is increased in CJD and Alzheimer disease other dementias.
    Neurology, 67(4): 710-2. [Abstract] [Full-text]
25. Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease.
    Neurology, 67(4): 660-5. [Abstract] [Full-text]
26. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
    J Neurochem, 98(5): 1610-8. [Abstract] [Full-text]
27. Linear patterns of Alzheimer's disease mutations along alpha-helices of presenilins as a tool for PS-1 model construction.
    J Neurochem, 98(5): 1560-72. [Abstract] [Full-text]
28. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.
    J Cereb Blood Flow Metab, 26(9): 1213-21. [Abstract] [Full-text]
29. Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease.
    Eur J Neurol, 13(9): 1022-5. [Abstract] [Full-text]
30. Risk factors for Alzheimer's disease in Russia: a case-control study.
    Eur J Neurol, 13(9): 990-5. [Abstract] [Full-text]
31. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Eur J Neurol, 13(9): 981-5. [Abstract] [Full-text]
32. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.
    Neurobiol Aging, 27(10): 1372-84. [Abstract] [Full-text]
33. BioVision: an application for the automated image analysis of histological sections.
    Neurobiol Aging, 27(10): 1462-76. [Abstract] [Full-text]
34. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease.
    Neurobiol Aging, 27(10): 1440-4. [Abstract] [Full-text]
35. Alzheimer-associated APP+1 transgenic mice: frameshift beta-amyloid precursor protein is secreted in cerebrospinal fluid without inducing neuropathology.
    Neurobiol Aging, 27(10): 1445-50. [Abstract] [Full-text]
36. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease.
    Neurobiol Aging, 27(10): 1431-4. [Abstract] [Full-text]
37. ApoE gene and familial risk of Alzheimer's disease as predictors of odour identification in older adults.
    Neurobiol Aging, 27(10): 1425-30. [Abstract] [Full-text]
38. Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.
    Neurobiol Aging, 27(10): 1416-24. [Abstract] [Full-text]
39. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease.
    Neurobiol Aging, 27(10): 1435-9. [Abstract] [Full-text]
40. Chinese Presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SY5Y neuroblastoma cells.
    Neurosci Lett, 406(1): 33-7. [Abstract] [Full-text]
41. Volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and Alzheimer's disease.
    Neurosci Lett, 406(1): 60-5. [Abstract] [Full-text]
42. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock".
    FASEB J, 20(11): 1874-6. [Abstract] [Full-text]
43. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.
    J Neurosci, 26(35): 9057-68. [Abstract] [Full-text]
44. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.
    J Neurosci, 26(35): 9047-56. [Abstract] [Full-text]
45. White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease.
    Stroke, 37(9): 2248-52. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.